Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination
- PMID: 38491184
- DOI: 10.1038/s41565-024-01615-3
Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination
Abstract
Multivalent presentation of ligands often enhances receptor activation and downstream signalling. DNA origami offers a precise nanoscale spacing of ligands, a potentially useful feature for therapeutic nanoparticles. Here we use a square-block DNA origami platform to explore the importance of the spacing of CpG oligonucleotides. CpG engages Toll-like receptors and therefore acts to activate dendritic cells. Through in vitro cell culture studies and in vivo tumour treatment models, we demonstrate that square blocks induce Th1 immune polarization when CpG is spaced at 3.5 nm. We observe that this DNA origami vaccine enhances DC activation, antigen cross-presentation, CD8 T-cell activation, Th1-polarized CD4 activation and natural-killer-cell activation. The vaccine also effectively synergizes with anti-PD-L1 for improved cancer immunotherapy in melanoma and lymphoma models and induces long-term T-cell memory. Our results suggest that DNA origami may serve as a platform for controlling adjuvant spacing and co-delivering antigens in vaccines.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Similar articles
-
Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.BMC Immunol. 2009 Aug 3;10:43. doi: 10.1186/1471-2172-10-43. BMC Immunol. 2009. PMID: 19650904 Free PMC article.
-
In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.J Immunother. 2007 Nov-Dec;30(8):789-97. doi: 10.1097/CJI.0b013e318155a0f6. J Immunother. 2007. PMID: 18049330
-
Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.Clin Exp Immunol. 2010 Oct;162(1):75-83. doi: 10.1111/j.1365-2249.2010.04226.x. Clin Exp Immunol. 2010. PMID: 20735440 Free PMC article.
-
Complexes of DNA vaccines with cationic, antigenic peptides are potent, polyvalent CD8(+) T-cell-stimulating immunogens.Methods Mol Med. 2006;127:159-69. doi: 10.1385/1-59745-168-1:159. Methods Mol Med. 2006. PMID: 16988454 Review.
-
Immunopharmacology of CpG DNA.Biol Chem. 2002 Oct;383(10):1491-500. doi: 10.1515/BC.2002.171. Biol Chem. 2002. PMID: 12452427 Review.
Cited by
-
A Synthetic Biology Approach for Vaccine Candidate Design against Delta Strain of SARS-CoV-2 Revealed Disruption of Favored Codon Pair as a Better Strategy over Using Rare Codons.Vaccines (Basel). 2023 Feb 20;11(2):487. doi: 10.3390/vaccines11020487. Vaccines (Basel). 2023. PMID: 36851364 Free PMC article.
-
DNA origami drives gene expression in a human cell culture system.Sci Rep. 2024 Nov 9;14(1):27364. doi: 10.1038/s41598-024-78399-y. Sci Rep. 2024. PMID: 39521857 Free PMC article.
-
Tailoring DNA Origami Protection: A Study of Oligolysine-PEG Coatings for Improved Colloidal, Structural, and Functional Integrity.ACS Polym Au. 2024 Dec 20;5(1):35-44. doi: 10.1021/acspolymersau.4c00085. eCollection 2025 Feb 12. ACS Polym Au. 2024. PMID: 39958528 Free PMC article.
-
Robust Accessibility of Addressable Sites in Defective DNA Origami.JACS Au. 2025 May 13;5(5):2237-2245. doi: 10.1021/jacsau.5c00206. eCollection 2025 May 26. JACS Au. 2025. PMID: 40443884 Free PMC article.
-
Functional DNA as a Molecular Tool in Regulating Immunoreceptor-Ligand Interactions.JACS Au. 2023 Jul 11;3(7):1820-1834. doi: 10.1021/jacsau.3c00291. eCollection 2023 Jul 24. JACS Au. 2023. PMID: 37502159 Free PMC article. Review.
References
-
- Klinman, D. M., Sato, T. & Shimosato, T. Use of nanoparticles to deliver immunomodulatory oligonucleotides. WIREs Nanomed. Nanobiotechnol. 8, 631–637 (2016). - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials